Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Effectiveness of Adcirca (Tadalafil) in Japanese Patients With Pulmonary Arterial Hypertension: Open-label, Non-interventional Observational Study in Japan

NCT01066845 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.

NCT NCT01066845
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01066845 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Effectiveness of Adcirca (Tadalafil) in Japanese Patients With Pulmonary Arterial Hypertension: Open-label, Non-interventional Observational Study in Japan
Lead sponsor
Eli Lilly and Company
Phase
Observational
Overall status
Completed
Start date
January 31, 2010
Completion date
August 31, 2014
Enrollment
1,809 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary arterial hypertension